ArticleMolecular therapy. Nucleic acids2022

Expanded targeting scope of LbCas12a variants allows editing of multiple oncogenic mutations.

Eunyoung Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.